NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 308 filers reported holding NATERA INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $254,601,802 | -13.1% | 5,753,713 | -4.4% | 0.01% | -12.5% |
| Q2 2023 | $292,814,326 | -4.3% | 6,017,557 | +9.2% | 0.01% | -11.1% |
| Q1 2023 | $305,880,999 | +36.8% | 5,509,384 | -1.0% | 0.01% | +28.6% |
| Q4 2022 | $223,623,940 | +3.9% | 5,566,939 | +13.4% | 0.01% | 0.0% |
| Q3 2022 | $215,191,000 | +27.9% | 4,910,809 | +3.4% | 0.01% | +40.0% |
| Q2 2022 | $168,246,000 | -29.4% | 4,747,363 | -19.0% | 0.01% | -16.7% |
| Q1 2022 | $238,455,000 | -63.6% | 5,861,732 | -16.4% | 0.01% | -64.7% |
| Q4 2021 | $654,734,000 | -15.7% | 7,010,757 | +0.6% | 0.02% | -22.7% |
| Q3 2021 | $776,260,000 | +21.3% | 6,965,721 | +23.6% | 0.02% | +22.2% |
| Q2 2021 | $639,709,000 | -2.1% | 5,634,698 | -12.4% | 0.02% | -5.3% |
| Q1 2021 | $653,108,000 | +5.2% | 6,432,039 | +3.1% | 0.02% | -5.0% |
| Q4 2020 | $620,736,000 | +55.7% | 6,237,294 | +13.0% | 0.02% | +33.3% |
| Q3 2020 | $398,752,000 | +53.8% | 5,519,813 | +6.1% | 0.02% | +50.0% |
| Q2 2020 | $259,333,000 | +80.9% | 5,201,226 | +8.3% | 0.01% | +42.9% |
| Q1 2020 | $143,354,000 | -14.5% | 4,800,850 | -3.5% | 0.01% | +16.7% |
| Q4 2019 | $167,649,000 | +15.5% | 4,976,224 | +12.4% | 0.01% | 0.0% |
| Q3 2019 | $145,166,000 | +8.7% | 4,425,751 | -8.6% | 0.01% | 0.0% |
| Q2 2019 | $133,552,000 | +133.3% | 4,842,318 | +74.4% | 0.01% | +100.0% |
| Q1 2019 | $57,247,000 | +49.1% | 2,776,341 | +0.9% | 0.00% | +50.0% |
| Q4 2018 | $38,401,000 | -42.4% | 2,750,858 | -1.2% | 0.00% | -33.3% |
| Q3 2018 | $66,679,000 | +69.8% | 2,785,208 | +33.5% | 0.00% | +50.0% |
| Q2 2018 | $39,274,000 | +142.4% | 2,086,829 | +19.4% | 0.00% | +100.0% |
| Q1 2018 | $16,205,000 | +2.9% | 1,748,063 | -0.2% | 0.00% | 0.0% |
| Q4 2017 | $15,741,000 | -30.3% | 1,750,931 | -0.1% | 0.00% | 0.0% |
| Q3 2017 | $22,590,000 | +22.4% | 1,752,476 | +3.1% | 0.00% | 0.0% |
| Q2 2017 | $18,455,000 | +43.6% | 1,699,447 | +17.3% | 0.00% | 0.0% |
| Q1 2017 | $12,855,000 | +15388.0% | 1,449,232 | +20415.7% | 0.00% | – |
| Q4 2016 | $83,000 | +6.4% | 7,064 | 0.0% | 0.00% | – |
| Q3 2016 | $78,000 | -8.2% | 7,064 | -0.0% | 0.00% | – |
| Q2 2016 | $85,000 | +8400.0% | 7,067 | +5294.7% | 0.00% | – |
| Q1 2016 | $1,000 | -93.3% | 131 | -90.6% | 0.00% | – |
| Q3 2015 | $15,000 | – | 1,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |